OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3026% below fair value
$7.01−0.30 (-4.10%)
Close on Nov 19, 2026Market cap $132.04MP/E 29.2Yield –
OptimizeRx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
OptimizeRx's free cash flow for the twelve months ending Jun 30, 2026 was $18.36M, up 77.5% year over year. For fiscal 2025 it was $18.66M, up 290.6% from the year before. Over ten years it grew 43.2% a year on average. The highest annual figure on record is $18.66M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.66M | +290.6% |
| FY2024 | Dec 31, 2024 | $4.78M | – |
| FY2023 | Dec 31, 2023 | -$7.33M | -169.3% |
| FY2022 | Dec 31, 2022 | $10.57M | +1589.8% |
| FY2021 | Dec 31, 2021 | $625.72K | – |
| FY2020 | Dec 31, 2020 | -$6.38M | – |
| FY2019 | Dec 31, 2019 | -$1.75M | -330.6% |
| FY2018 | Dec 31, 2018 | $758.19K | – |
| FY2017 | Dec 31, 2017 | -$1.52M | – |
| FY2016 | Dec 31, 2016 | -$644.40K | -225.6% |
| FY2015 | Dec 31, 2015 | $513.06K | – |
| FY2014 | Dec 31, 2014 | -$63.33K | -105.6% |
| FY2013 | Dec 31, 2013 | $1.13M | – |
| FY2012 | Dec 31, 2012 | -$626.26K | – |
| FY2011 | Dec 31, 2011 | -$534.61K | – |
| FY2010 | Dec 31, 2010 | -$1.31M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.58M | +88.4% |
| Q1 FY2026 | Mar 31, 2026 | -$488.00K | -112.7% |
| Q4 FY2025 | Dec 31, 2025 | $7.08M | +3809.9% |
| Q3 FY2025 | Sep 30, 2025 | $3.19M | +80.0% |
| Q2 FY2025 | Jun 30, 2025 | $4.55M | +517.5% |
| Q1 FY2025 | Mar 31, 2025 | $3.84M | +83.9% |
| Q4 FY2024 | Dec 31, 2024 | $181.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.77M | +23.2% |
| Q2 FY2024 | Jun 30, 2024 | $737.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $2.09M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.26M | -324.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.44M | -64.6% |
| Q2 FY2023 | Jun 30, 2023 | -$2.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$114.58K | -161.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.79M | +1577.8% |
| Q1 FY2022 | Mar 31, 2022 | $4.07M | +147.0% |
| Q4 FY2021 | Dec 31, 2021 | -$1.37M | – |
| Q3 FY2021 | Sep 30, 2021 | $186.02K | – |
| Q2 FY2021 | Jun 30, 2021 | $166.12K | +40.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$126.85K | -114.5% |
| Q2 FY2020 | Jun 30, 2020 | $118.58K | -87.1% |
| Q1 FY2020 | Mar 31, 2020 | -$3.75M | -451.5% |
| Q2 FY2019 | Jun 30, 2019 | -$115.66K | – |
| Q1 FY2019 | Mar 31, 2019 | $876.12K | – |
| Q4 FY2018 | Dec 31, 2018 | $921.53K | – |
| Q3 FY2018 | Sep 30, 2018 | $1.07M | – |
| Q2 FY2018 | Jun 30, 2018 | -$440.26K | – |
| Q1 FY2018 | Mar 31, 2018 | -$791.19K | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.72K | – |
| Q3 FY2017 | Sep 30, 2017 | -$793.66K | -1395.8% |
| Q2 FY2017 | Jun 30, 2017 | -$407.31K | -493.9% |
| Q1 FY2017 | Mar 31, 2017 | -$313.38K | – |
| Q4 FY2016 | Dec 31, 2016 | -$508.46K | – |
| Q3 FY2016 | Sep 30, 2016 | $61.25K | – |
| Q2 FY2016 | Jun 30, 2016 | $103.41K | – |
| Q1 FY2016 | Mar 31, 2016 | -$300.59K | – |
See a number that looks wrong?